$1 Million Bet on a Cure: Reprogramming the Immune System To Stop Type 1 Diabetes

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...
News-Medical.Net

Reprogramming immunity to protect beta cells in type 1 diabetes

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
GEN - Genetic Engineering and Biotechnology News

Glia Reprogrammed into Parvalbumin Interneurons Show Promise for Brain Repair

Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.